妇科恶性肿瘤患者的生育力保存：韩国生育力保存学会临床指南
Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.
作者信息
Lee Sanghoon, Kim Seul Ki, Hwang Kyung Joo, Kim Tak, Kim Seok Hyun
机构信息
Department of Obstetrics and Gynecology, Korea University College of Medicine, Seoul, Korea.
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
出版信息
Clin Exp Reprod Med. 2017 Dec;44(4):175-180. doi: 10.5653/cerm.2017.44.4.175. Epub 2017 Dec 31.
Abstract
Fertility preservation plays a central role in cancer care since an increasingly large number of cancer patients are surviving as a result of improvements in diagnostic and therapeutic strategies. Physicians who take part in the initial diagnosis and management of gynecologic cancer should understand the importance of fertility preservation. Since indications for fertility preservation are limited to early-stage gynecologic cancer, a surgeon must carefully consider each indication. Before performing fertility-sparing surgery, health professionals should compare its oncologic and pregnancy outcomes with those of other standard treatments. Individualized treatment strategies should be delivered depending on the patient's situation, and physicians should provide timely information and appropriate counseling.
摘要
随着诊断和治疗策略的改进，越来越多的癌症患者得以存活，生育力保存在癌症治疗中发挥着核心作用。参与妇科癌症初始诊断和管理的医生应了解生育力保存的重要性。由于生育力保存的适应证仅限于早期妇科癌症，外科医生必须仔细考虑每一项适应证。在进行保留生育功能的手术前，医疗专业人员应将其肿瘤学和妊娠结局与其他标准治疗方法的结局进行比较。应根据患者情况提供个体化的治疗策略，医生应及时提供信息并给予适当的咨询。
相似文献
1
Fertility preservation for patients with gynecologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.妇科恶性肿瘤患者的生育力保存：韩国生育力保存学会临床指南
Clin Exp Reprod Med. 2017 Dec;44(4):175-180. doi: 10.5653/cerm.2017.44.4.175. Epub 2017 Dec 31.
2
Fertility preservation in women with cancer.癌症女性的生育力保存
Clin Exp Reprod Med. 2012 Jun;39(2):46-51. doi: 10.5653/cerm.2012.39.2.46. Epub 2012 Jun 30.
3
Fertility preservation in women with early-stage gynecologic cancer: optimizing oncologic and reproductive outcomes.妇科早期癌症患者的生育力保存：优化肿瘤学和生殖结局。
Int J Gynecol Cancer. 2021 Mar;31(3):345-351. doi: 10.1136/ijgc-2020-001328. Epub 2020 Jun 21.
4
Fertility after the treatment of gynecologic tumors.妇科肿瘤治疗后的生育能力。
Recent Results Cancer Res. 2008;178:79-95. doi: 10.1007/978-3-540-71274-9_9.
5
Fertility preserving management in gynecologic cancer patients: the need for centralization.妇科癌症患者的生育力保护管理：需要集中化。
Int J Gynecol Cancer. 2010 Dec;20(9):1613-9. doi: 10.1111/IGC.0b013e3181f936ff.
6
Fertility considerations prior to conservative management of gynecologic cancers.妇科癌症保守治疗前的生育力考虑因素。
Int J Gynecol Cancer. 2021 Mar;31(3):339-344. doi: 10.1136/ijgc-2020-001783. Epub 2020 Nov 11.
7
Factors influencing fertility-sparing treatment for gynecologic malignancies: A survey of Society of Gynecologic Oncology members.影响妇科恶性肿瘤保留生育功能治疗的因素：妇科肿瘤学会成员调查
Gynecol Oncol. 2017 Dec;147(3):497-502. doi: 10.1016/j.ygyno.2017.09.019. Epub 2017 Sep 21.
8
Fertility preservation for patients with hematologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.血液系统恶性肿瘤患者的生育力保存：韩国生育力保存学会临床指南
Clin Exp Reprod Med. 2017 Dec;44(4):187-192. doi: 10.5653/cerm.2017.44.4.187. Epub 2017 Dec 31.
9
Fertility preserving treatment for gynecologic malignancies: a review of recent literature.妇科恶性肿瘤的生育保存治疗：文献复习。
Curr Opin Obstet Gynecol. 2020 Feb;32(1):51-56. doi: 10.1097/GCO.0000000000000604.
10
A prospective study of women and girls undergoing fertility preservation due to oncologic and non-oncologic indications in Sweden-Trends in patients' choices and benefit of the chosen methods after long-term follow up.一项针对因肿瘤和非肿瘤原因接受生育力保存的女性和女孩的前瞻性研究——瑞典：在长期随访后，患者选择和所选择方法获益的趋势。
Acta Obstet Gynecol Scand. 2019 May;98(5):604-615. doi: 10.1111/aogs.13559. Epub 2019 Mar 18.
引用本文的文献
1
Awareness and perceptions of Filipino obstetrician-gynecologists on fertility preservation: a cross-sectional survey.菲律宾妇产科医生对生育力保存的认知和看法：一项横断面调查。
BMC Womens Health. 2023 May 25;23(1):285. doi: 10.1186/s12905-023-02436-7.
2
Role of Stem Cells in the Ovarian Tissue Cryopreservation and Transplantation for Fertility Preservation.干细胞在卵巢组织冻存和移植中的作用，用于保存生育能力。
Int J Mol Sci. 2021 Nov 19;22(22):12482. doi: 10.3390/ijms222212482.
3
Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.化疗和放疗诱导的卵巢损伤的分子机制与防治策略。
Int J Mol Sci. 2021 Jul 13;22(14):7484. doi: 10.3390/ijms22147484.
4
Changes in telomere length and senescence markers during human ovarian tissue cryopreservation.人类卵巢组织冷冻保存过程中端粒长度和衰老标志物的变化
Sci Rep. 2021 Jan 26;11(1):2238. doi: 10.1038/s41598-021-81973-3.
5
Magnetic resonance relaxometry improves the accuracy of conventional MRI in the diagnosis of endometriosis-associated ovarian cancer: A case report.磁共振弛豫测量法提高了传统MRI诊断子宫内膜异位症相关卵巢癌的准确性：一例报告。
Mol Clin Oncol. 2019 Sep;11(3):296-300. doi: 10.3892/mco.2019.1889. Epub 2019 Jul 1.
6
Comparison between Slow Freezing and Vitrification for Human Ovarian Tissue Cryopreservation and Xenotransplantation.慢速冻与玻璃化法在人卵巢组织冻存及异种移植中的比较。
Int J Mol Sci. 2019 Jul 8;20(13):3346. doi: 10.3390/ijms20133346.
7
Investigation of Each Society for Fertility Preservation in Asia.亚洲各生育力保存协会调查。
Front Endocrinol (Lausanne). 2019 Mar 14;10:151. doi: 10.3389/fendo.2019.00151. eCollection 2019.
8
Ovarian tissue cryopreservation and transplantation in patients with cancer.癌症患者的卵巢组织冷冻保存与移植
Obstet Gynecol Sci. 2018 Jul;61(4):431-442. doi: 10.5468/ogs.2018.61.4.431. Epub 2018 Jun 28.
本文引用的文献
1
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.骨髓增殖性肿瘤 2.2017 年版，NCCN 肿瘤临床实践指南。
J Natl Compr Canc Netw. 2016 Dec;14(12):1572-1611. doi: 10.6004/jnccn.2016.0169.
2
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.韩国子宫体癌管理实践指南：韩国妇科肿瘤学会共识声明
J Gynecol Oncol. 2017 Jan;28(1):e12. doi: 10.3802/jgo.2017.28.e12. Epub 2016 Oct 27.
3
Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success.宫颈癌的保留生育功能管理：平衡肿瘤学结局与生殖成功。
Gynecol Oncol Res Pract. 2016 Oct 21;3:9. doi: 10.1186/s40661-016-0030-9. eCollection 2016.
4
Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer.早期上皮性卵巢癌保留生育功能治疗与标准根治性手术的长期结果比较。
Br J Cancer. 2016 Sep 6;115(6):641-8. doi: 10.1038/bjc.2016.254. Epub 2016 Aug 18.
5
Fertility results and pregnancy outcomes after conservative treatment of cervical cancer: a systematic review of the literature.宫颈癌保守治疗后的生育结局和妊娠结局：文献系统评价。
Fertil Steril. 2016 Oct;106(5):1195-1211.e5. doi: 10.1016/j.fertnstert.2016.06.032. Epub 2016 Jul 16.
6
Oncological outcomes after fertility-sparing surgery for cervical cancer: a systematic review.保留生育功能的宫颈癌手术的肿瘤学结局：系统综述。
Lancet Oncol. 2016 Jun;17(6):e240-e253. doi: 10.1016/S1470-2045(16)30032-8.
7
Progestins in the fertility-sparing treatment and retreatment of patients with primary and recurrent endometrial cancer.孕激素在原发性和复发性子宫内膜癌患者保留生育功能治疗及再次治疗中的应用
Oncologist. 2015 Mar;20(3):270-8. doi: 10.1634/theoncologist.2013-0445. Epub 2015 Feb 11.
8
Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.卵巢交界性肿瘤的保守性手术：一项侧重于复发风险的荟萃分析
Eur J Cancer. 2015 Mar;51(5):620-31. doi: 10.1016/j.ejca.2015.01.004. Epub 2015 Feb 3.
9
Fertility sparing surgery in early stage epithelial ovarian cancer.早期上皮性卵巢癌的保留生育功能手术
J Gynecol Oncol. 2014 Oct;25(4):320-7. doi: 10.3802/jgo.2014.25.4.320. Epub 2014 Jun 18.
10
Endometrial cancer: a review and current management strategies: part II.子宫内膜癌：综述与当前管理策略：第二部分。
Gynecol Oncol. 2014 Aug;134(2):393-402. doi: 10.1016/j.ygyno.2014.06.003. Epub 2014 Jun 11.
Zotero 插件